ライフサイエンスコーパス: vasopressin V2 receptor

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 cause of its lack of agonist activity at the vasopressin V2 receptor.

2 and beta2-adrenergic receptors, but not the vasopressin (V2) receptor.

3 iven fluid secretion (PDE3), and response to vasopressin V2 receptor activation (both).

4 than the mixed vasopressin type 1a receptor/vasopressin V2 receptor agonist arginine vasopressin bec

5 treatment of selepressin with the selective vasopressin V2 receptor agonist desmopressin were simila

6 This study sought to examine the effects of vasopressin V2 receptor antagonism with tolvaptan on the

7 d effects were blocked by treatment with the vasopressin V2 receptor antagonist SR121463B, but not by

8 mice before and after administration of the vasopressin V2 receptor antagonist tolvaptan.

9 aptan (OPC-41061), a novel, oral, nonpeptide vasopressin V2-receptor antagonist in patients with chro

10 he effect of long-term administration of the vasopressin V2-receptor antagonist tolvaptan (30 mg/day)

11 atinine clearance, >/=60 ml per minute), the vasopressin V2-receptor antagonist tolvaptan slowed the

12 Tolvaptan, an oral, nonpeptide, selective vasopressin V2-receptor antagonist, shows promise in thi

13 ypervolemic hyponatremia, tolvaptan, an oral vasopressin V2-receptor antagonist, was effective in inc

14 inhibition of renal intracellular cAMP using vasopressin V2 receptor antagonists, and somatostatin an

15 Vaptans acting on the vasopressin V2 receptors (aquaretics) have attracted att

16 isease caused most often by mutations in the vasopressin V2 receptor (AVPR2).

17 One group of nephrotic rats received a vasopressin V2 receptor blocker (V2X) from 4 to 16 wk af

18 Tolvaptan, a vasopressin V2 receptor blocker, shows promise for manag

19 The data support roles for multiple vasopressin V2-receptor-dependent signaling pathways in

20 Functional engagement of vasopressin V2 receptors is reported to produce rises in

21 We conclude that vasopressin V2 receptors mediate the antidiuretic effect

22 eamino-(8-D-arginine)-vasopressin (dDAVP), a vasopressin V2 receptor-selective agonist, for 7 d into

23 unctional, shortened, "diabetic" form of the vasopressin V2 receptor that is the product of incomplet

24 asopressin (AVP) affects kidney function via vasopressin V2 receptors that are linked to activation o

25 II type 1A receptor, neurotensin receptor 1, vasopressin V2 receptor, thyrotropin-releasing hormone r

26 After agonist-induced internalization, the vasopressin V2 receptor (V2R) does not recycle to the pl

27 The seven-transmembrane-spanning vasopressin V2 receptor (V2R) is a Gs-coupled receptor t

28 to recycle and resensitize rapidly, and the vasopressin V2 receptor (V2R), known to recycle and rese

29 OPC-31260, a vasopressin V2 receptor (VPV2) antagonist, was shown to

30 The vasopressin V2 receptor (VPV2R) antagonist OPC31260 has

31 ous to the human disorders to test whether a vasopressin V2 receptor (VPV2R) antagonist, OPC31260, wo

32 beta2-adrenergic, angiotensin II type 1 and vasopressin V2 receptors was altered by the beta-arresti

33 -7 cells, we found that angiotensin AT1a and vasopressin V2 receptors, which form stable receptor-bet

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。